chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Also spotted medium bright  red  blood  in his  urine; Blood and several small dark clots  in his stool and it happened  3  times during the day; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATOCHEZIA (Blood and several small dark clots  in his stool and it happened  3  times during the day) and BLOOD URINE PRESENT (Also spotted medium bright  red  blood  in his  urine) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB for an unknown indication.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced HAEMATOCHEZIA (Blood and several small dark clots  in his stool and it happened  3  times during the day) (seriousness criterion medically significant). On 12-Aug-2021, the patient experienced BLOOD URINE PRESENT (Also spotted medium bright  red  blood  in his  urine) (seriousness criterion medically significant). The patient was treated with OMEGA-3 FATTY ACIDS ongoing since an unknown date for Blood in stool and Blood in urine, at a dose of 1 dosage form; CYANOCOBALAMIN (VITAMIN B-12) ongoing since an unknown date for Blood in stool and Blood in urine, at a dose of 1 dosage form and UBIDECARENONE (CO Q-10) ongoing since an unknown date for Blood in stool and Blood in urine, at a dose of 1 dosage form. At the time of the report, HAEMATOCHEZIA (Blood and several small dark clots  in his stool and it happened  3  times during the day) and BLOOD URINE PRESENT (Also spotted medium bright  red  blood  in his  urine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant product used included a garlic tablet, supplements to treat the symptoms, unspecified medications for anxiety and pain, two inhalers, a nasal inhaler and an allergy medication.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
expired vaccine administered; The patient experienced no symptoms; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. No information was provided regarding the patient's historical conditions, previous drug reactions, allergies, concurrent conditions or concomitant medications.  On 19-JAN-2016, the patient was vaccinated with an expired dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) subcutaneously for prophylaxis, lot # J016233 and expiration date 19-DEC-2015 (dose, strength and frequency were not reported).  It was reported that the patient experienced no symptoms.
confusion reported by family since the covid vaccine was administered - came to hospital ED 7 days later and multiple acute ischemic strokes were identified. also noted to be hypertensive and diabetic, previously undiagnosed.
Pt had vasovagal response after receiving three immunizations. Pale and diaphoretic. Pt placed in supine position. Recovered well and released.
Received vaccine about 11 am; within an hr, developed quarter sized hard knot at injection site, area tender & became unable to raise LA without difficulty.  Experienced nausea & malaise for remainder of evening.  The next day arm slightly tender, symptoms completely resolved in 36 hrs.
Body aches and ringing in my ears started about 5 hours after the shot. I went to bed at 10pm thinking I was feeling ?fine?.  I woke up at 1am, covered in sweat, nauseous and the room was spinning. I stood up because I thought I was going to throw up and lost consciousness. After a few minutes my husband called 911 because I was non responsive and vomiting.  I gained consciousness as the paramedics were arriving, but had slurred speech and couldn?t see clearly. As they took me to the hospital I was awake and speaking but extremely weak. They did an ecg. At the hospital they did a blood test and ecg. They gave me an IV of fluids which helped. They had a hard time getting my blood pressure for the first few minutes, trying multiple cuffs.  Ultimately, they said the echo looked ok, so they discharged me since I was no longer having an emergency episode and advised that I follow up with my primary and cardiologist
symptoms of liver failure. Liver seems to be shutting down.; began to feel ill, illness continued over time; Jaundice; This is a spontaneous report from a contactable consumer. A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose at the age of 68-years-old via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose on an unspecified date for covid-19 immunisation. It was reported that within 24hrs of receiving the vaccine on 20Feb2021, the patient began to feel ill, illness continued over time, eventually when to doctor and presented symptoms of liver failure. Liver seems to be shutting down. Jaundice has set in over the past 5 days. It was unknown if the patient received any treatment for the events. The patient did not recover from the events.  Information on the lot/batch number has been requested.
10 day post vax, the pt experienced blotchy, discrete pink to red irregular bordered rash, blanched with pressure. Non pruritic, no fever. Rash started on trunk and spread over extremities to face.
This is a spontaneous report from a contactable consumer. A patient of unspecified age ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced stomach issues on an unspecified date. The outcome of the event was unknown. The consumer also asked if there had been previous reports of patients having "undigested lactose products in their stool" after receiving pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) and if the vaccine could produce allergic reactions in lactose intolerant patients.
She got a rash all over her back, stomach and is now spreading to face, very irritable and tired, so far no fever. Haven't brought her in to the dr yet. Called the nurse line to advise.
Headache; burning when she pees; Burning in my chest/burning when she pees; Chest congestion; Urinary symptoms/a little bit of difficulty peeing; Terrible back pain where I couldn't walk; Terrible back pain where I couldn't walk; The pain takes her breath away; This is a spontaneous report from a contactable consumer (patient). A 52-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm on 12Mar2021 02:00 (at the age of 52-years-old) as Dose 1, Single for covid-19 immunization. The medical history included back issues were diagnosed prior to having the Pfizer COVID Vaccine, and back surgeries on 1st was in 1999 and her other surgeries were prior to receiving the Pfizer COVID. The patient's concomitant medications were not reported. Patient did not receive any prior vaccinations within 4 weeks. Patient reported no relevant family medical history. Patient reported that just got her 1st dose on Friday on 12Mar2021 and was fine on Saturday but woke up at 3:00am on Sunday morning on 14Mar2021 and started having some reactions to the Pfizer COVID Vaccine and reported that "I woke up with a mild reaction of a headache, burning in my chest, had burning when pees and a little bit of difficulty peeing as well, chest congestion and urinary symptoms". Patient had "terrible back pain where I couldn't walk". And reported that "it eased up some yesterday but still when I walk even with sitting I'm having difficulty". Patient reported she had not had treatment for the reported events but the last symptom, which was terrible back pain was still going on and was the worst symptom. Terrible back pain to the point of when she got up on Sunday at 3:00am, she could not walk and could not take a step and could not walk; states the back pain has improved some and she could walk but the pain takes her breath away when it happens; states the back pain was straight across the middle of her back and was still there. Patient stated she was home from work today because of the back pain Patient stated that she was used to back pain and handles pain very well but this was severe and was severe compared to what she has had with back surgeries before. The patient did not receive any treatment for events. Patient did not any AE(s) require a visit to emergency room and physician office. No hospitalization. The patient was not recovered from the events headache, back pain, walking difficulty and breathing difficult and was recovered from the events micturition burning, chest burning, chest discomfort on Mar2021 and was recovering from the event urination difficulty at the time of report.   No follow-up attempts are needed. No further information is expected.
Axillary Lymphadenopathy that started after the vaccine was given (7/17/18) and still present when pt was seen again on 7/30/18.
patient received less than the recommended dose; syringe malfunction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL UNDERDOSE (patient received less than the recommended dose) and SYRINGE ISSUE (syringe malfunction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced ACCIDENTAL UNDERDOSE (patient received less than the recommended dose) and SYRINGE ISSUE (syringe malfunction). On 16-Mar-2021, ACCIDENTAL UNDERDOSE (patient received less than the recommended dose) and SYRINGE ISSUE (syringe malfunction) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of Underdose and syringe issue, for mRNA-1273, lot # unknown,  with no associated AEs.; Sender's Comments: This report refers to a case of Underdose and syringe issue, for mRNA-1273, lot # unknown,  with no associated AEs.
her arm sore; pain in the injections site; could barely move her arm; This is a spontaneous report received from a non-contactable consumer from medical information team. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 17Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 17Mar2021, outcome "unknown", described as "her arm sore"; VACCINATION SITE PAIN (non-serious) with onset 17Mar2021, outcome "unknown", described as "pain in the injections site"; MOBILITY DECREASED (non-serious) with onset 17Mar2021, outcome "unknown", described as "could barely move her arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sudden onset malignant symptomatic orthostatic HYPERtension, hospital visit, not controlled with multiple meds, unstable, currently tapering off of very high dose steroids which have been only thing to help during this 2 months and I am starting to deteriorate again. I am an MD and have been unable to work for 2 months. No one has seen anything like this. Who can help me?
First 3 days - eyes burning, throat burning, fever, painful lymph nodes under chin, arm pits, chest.   Increased tinnitus.  As those got better, dizziness increased.   As of 4th day and still continuing, have vertigo with visual swirling and intense spinning.   Spinning worse when laying down or turning head quickly.  I have contacted my doctor to schedule an appt but have not gone to ER
The patient presented with fever 38.4 since may 20 2021 in the morning. the patient is taking for the fever motrin 200 every 6 hrs for the fever.
She received vaccinations-HPV first dose and influenza. She came back into the office shortly after stating she has a rash around the site where she received the HPV vaccine-right arm. Also a rash on her right upper part of her thumb. Vitals were checked and normal. PCP evaluated her. She is going to receive Benadryl 0.3 ML via dorsogluteal. Safety alert was put in. She was informed to wait about 15 minutes after receiving the Benadryl injection but she decided to leave as her ride was waiting on her. Followed up with patient to see how she was doing. She is doing good. Just sleepy.
Polymyalgia; Felt like truck hit me; Slight fever; Aches in shoulders, neck, hands and hip area; Could not get out of chair without assistance or reach above my head; Flu like feeling; This case was reported by a consumer via call center representative and described the occurrence of polymyalgia in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th July 2019, the patient received the 1st dose of Shingrix. On 18th July 2019, 1 days after receiving Shingrix, the patient experienced polymyalgia, feeling abnormal, fever, general body pain, mobility decreased and influenza like illness. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the polymyalgia, feeling abnormal, general body pain, mobility decreased and influenza like illness were not recovered/not resolved and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the polymyalgia, feeling abnormal, fever, general body pain, mobility decreased and influenza like illness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but could be between 72 to 73 years. The patient felt like truck hit, slight fever and aches in pains in shoulders, neck, hands and hip area. The patient could not get out of chair without assistance or reach above my head. The patient was having flu like feeling also. The patient had numerous x rays and blood work from family doctor and also Rheumatoid Specialist. The patient was diagnosed with Polymyalgia and had been on heavy steroids. The patient stated that will not be getting the booster dose of Shingrix. The patient was upset for getting the vaccine. The patient suggested to do more testing on People with arthritis and autoimmune diseases as they may not want to get it.      Lab Comments: on an unknown date numerous x rays and blood work were done
Vaccine was administered to high in the deltoid muscle.  Pt experiencing nerve pain at time of injection.
CHILD TAKEN TO PHYSICIAN ON 1/10/08 FOR SYMPTOMS OF BULGING FONTANELLE.  HAD RECEIVED IMMUNIZATIONS ON 1-7-08.  EVALUATED BY PHYSICIAN, SPINAL TAP NEGATIVE FOR MENINGITIS, LAB WORK WITHIN NORMAL LIMITS.  CHILD DID NOT APPEAR ILL.  CHILD RELEASED TO HOME.
Patient came into the clinic complaining about rash all over body. The Pt. stated that he had been abroad the weekend prior. From what the note from the Doctor stated was he was given an I.V. antibotic and this caused to the Doctor here to understand it was this that cause the rash to spread even future.
T103-104 when got home called MD;back to MD office temp lowered;pt lethargic & limp;noted fontanel was bulging;MD stated had adverse rxn to DTP;ill x 5 days;pt in special education since convuls;pt no 15yr old;depression;viral illness
Received vaccine on 12/22/20, on 12/25/20 noticed redness, hives, and itching on the left arm where received vaccine. Took Benadryl on 12/25/20 and 12/26/20.  Reported on 12/29/20, and feels itching with some redness subsiding, no pain.
Bled a lot. Bruise the size of softball x 3 weeks. Pain and limited mobility of right arm/shoulder.
Fever; Wrong vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Fever) and WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) in a 69-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS5051C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jan-2023, the patient experienced PYREXIA (Fever) and WRONG PRODUCT ADMINISTERED (Wrong vaccine administered). On 19-Jan-2023, PYREXIA (Fever) had resolved. At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Patient had fever for one day.   Treatment information was not reported.  The number was reported.
58-year-old male, history of Down syndrome, who presented from his care facility for approximately one week of progressive fatigue, lethargy, reduced mentation, along with reduced intake, who was found to be less responsive.  He was brought to the emergency department where he was found to be hypothermic, hypotensive, hypoxic, and bradycardic.  Upon admission to the ED, POLST form discovered _____ DNR, but limited medical interventions.  He was then discovered to have COVID-19 pneumonia, likely driving this entire process.
lesion warm to touch; red mark on the area of the injection; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (lesion warm to touch) and ERYTHEMA (red mark on the area of the injection) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced FEELING HOT (lesion warm to touch) and ERYTHEMA (red mark on the area of the injection). At the time of the report, FEELING HOT (lesion warm to touch) and ERYTHEMA (red mark on the area of the injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Patient reported onset of mild headache immediately following injection of vaccine. Resolved after 30 min observation.
A few hours after receiving the shot I felt full in my stomach and a little tired.   By the evening I was throwing up violently for several hours.   The next day I had a headache and was extremely tired.
About 10 minutes after receiving vaccine the patient developed tightness in his throat,anxiety,redness in face and hands and shortness of breath.The patient was given epinephrine 0.3 mg intramuscularly in his left lateral thigh at 11:10 am.The patient responded nicely to the epinephrine and vs at 11:20 were bp 138/68,pulse 102,pulse oximeter 95%.His treatment occurred at the vaccination site. He then was transferred to our local emergency room and was observed for 2 hours.His symptoms abated and he was discharged. He informed us that he had received a moderna vaccine on 01/28/2021 without complications.We learned this after his vaccination.
aches, tired, fever, chills, sweats in the night, diahrrea, no apetite, skin hurt, low energy.  All increased over the next 3 days, and by 6 pm on March 6, I started feeling human again.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 08-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
1PM TC fr mom states site of inject & remainder lt leg swollen, feet "blue" when socks off states infant irritable adv to bring infant to clinic ASAP. Seen by MD no signs of swelling infant happy, smiling, using leg s/problem, t 99.6(R).
had a vasovagal reaction within 5 minutes of receiving second moderna shot. BP and HR dropped, clammy and sweating, bradycardia. patient was sat down in a chair and given an ice pack for the back of the neck and a coke and water to drink. patient had slurred speech. after about 10 minutes patient started to regain color and stopped sweating. within 30 minutes patient stated he was at about 75% back to normal. after monitoring for 1 hour post vaccine, patient felt comfortable enough to leave.
Day 1 Headache, nausea TYLENOL. Day 2 Upper arm swollen, red, fever 102 TYLENOL. Day 3 All joints painful, generalized weakness, fever, HA, nausea TYLENOL. Day 4 Left arn itching ice pack. Day 5 Swelling decreased.
Information has been received from a pharmacist via a company representative referring to a 60 years old female patient. Pertinent medical history and drug reactions/allergies were not reported. On 02-SEP-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # K010630, expiration date 30-OCT-2015) (dose and route were not reported). Concomitant drug was not reported. In a couple of days after the injection (on an unknown date in September 2015), the patient developed a red, itchy rash at the injectionn site. On 11-SEP-2015, the patient spoke with the pharmacist and the red, itchy rash was still present. The causality was not reported. Additional information has been requested.